The Pennsylvania Department of Drug and Alcohol Programs (DDAP) has issued Information Bulletin 01-2024, reminding single county authorities (SCA) and residential treatment providers about obligations regarding individuals on high doses of medication for opioid use disorder (MOUD). It emphasizes adherence to Part 4.04 of the Case Management and Clinical Services Manual and relevant licensure standards. It states that SCAs must ensure providers do not exclude individuals using MOUD and that treatment is individualized without restrictions. Providers may lose funds for restricting admission based on medication use. For additional questions, treatment providers can contact the Bureau of Program Licensure, and SCAs can contact the Treatment Division.